Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.88 USD | +2.49% | +3.62% | +15.20% |
Apr. 25 | OncoCyte Corporation announced that it has received $15.807655 million in funding | CI |
Apr. 16 | Broadwood Capital, Inc. Engages with OncoCyte Corporation | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.20% | 37.55M | |
+2.74% | 108B | |
+10.02% | 105B | |
+1.72% | 23.46B | |
-11.58% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-7.39% | 17.19B | |
+6.45% | 13.99B | |
+35.27% | 12.53B |
- Stock Market
- Equities
- OCX Stock
- News OncoCyte Corporation
- OncoCyte Says VitaGraft Kidney Diagnostic Test to Receive Medicare, Medicaid Coverage